The company states that each batch undergoes three separate rounds of testing at independent third-party laboratories: Testing Round 1 Identity Verification: According to the company, this confirms the product contains actual BPC-157 rather than filler or substitute compounds, using analytical techniques like mass spectrometry to verify the molecular structure matches authentic BPC-157
Histological analysis revealed that Dihexa treatment increased neuronal cell counts and enhanced expression of synaptophysin (SYP), a presynaptic protein marker indicating synaptic density, in the hippocampus of APP/PS1 mice
Additionally, these medications improve cardiovascular risk factorsreducing blood pressure, improving lipid profiles, and decreasing systemic inflammationall of which contribute to the metabolic milieu that drives fatty liver disease
Int J Mol Sci 25:11672
doi: 10.1093/jn/135.7.1609
People recovering from surgery, dealing with chronic joint pain, or seeking faster muscle and tendon recovery are increasingly turning to BPC157 to support their health goals